• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Why BlackBerry Shares Are Trading Lower By Over 5%; Here Are 20 Stocks Moving Premarket

    12/21/23 7:46:57 AM ET
    $ACON
    $ATAK
    $BB
    $DUNE
    Medical Specialities
    Health Care
    Blank Checks
    Finance
    Get the next $ACON alert in real time by email

    Shares of BlackBerry Limited (NYSE:BB) moved lower in pre-market trading following the release of third-quarter results.

    BlackBerry reported quarterly earnings of 1 cent per share which exceeded the Street's estimate of losses of 3 cents per share, according to Benzinga Pro. The company also said it sees fourth-quarter revenue of $150 million to $159 million.

    BlackBerry shares fell 5.4% to $3.88 in pre-market trading.

    Here are some other stocks moving in pre-market trading.

    Gainers

    • Infrared Cameras Holdings Inc (NASDAQ:MSAI) rose 213% to $8.20 in pre-market trading after falling over 61% on Wednesday.
    • Mobile Global Esports Inc.(NASDAQ:MGAM) gained 53.4% to $0.4294 in pre-market trading after falling 4% on Wednesday.
    • Mesoblast Limited (NASDAQ:MESO) shares gained 32.1% to $1.40 in pre-market trading. Mesoblast recently reported placement and accelerated non-renounceable entitlement offer to raise up to A$97 million.
    • ParaZero Technologies Ltd. (NASDAQ:PRZO) shares surged 30.9% to $1.61 in pre-market trading. ParaZero shares jumped over 75% on Wednesday after the company announced the successful completion of its safety solution development for a Fortune 500 leading global automotive manufacturer's proprietary drone program.
    • 60 Degrees Pharmaceuticals, Inc. (NASDAQ:SXTP) shares rose 27.4% to $1.49 in pre-market trading after jumping 36% on Wednesday.
    • Aurora Technology Acquisition Corp.. (NASDAQ:ATAK) shares gained 26.1% to $5.56 in pre-market trading after falling 15% on Wednesday.
    • Edgio, Inc. (NASDAQ:EGIO) shares climbed 25% to $0.4313 in pre-market trading after declining around 10% on Wednesday.
    • PetVivo Holdings, Inc. (NASDAQ:PETV) shares rose 23.2% to $1.01 in pre-market trading.
    • Inovio Pharmaceuticals, Inc. (NASDAQ:INO) gained 14% to $0.44 in pre-market trading.
    • Micron Technology, Inc. (NASDAQ:MU) rose 5.7% to $83.21 in pre-market trading after the company reported mixed first-quarter financial results and issued strong guidance.

    Losers

    • Polished.com Inc. (NYSE:POL) shares fell 40.3% to $4.54 in pre-market trading after jumping 618% on Wednesday.
    • Nogin, Inc. (NASDAQ:NOGN) shares fell 28.6% to $0.0800 in pre-market trading after dipping over 30% on Wednesday.
    • Aclarion, Inc. (NASDAQ:ACON) shares fell 16.9% to $0.2899 in pre-market trading. Aclarion shares rose over 19% on Wednesday after the company was granted U.S. patent #11844601 for "MR SPECTROSCOPY SYSTEM FOR DIAGNOSING PAINFUL AND NON-PAINFUL INTERVERTEBRAL DISCS (Severe Low Back Pain)."
    • Dune Acquisition Corporation (NASDAQ:DUNE) fell 15.6% to $3.90 in pre-market trading after gaining 6% on Wednesday.
    • Gaucho Group Holdings, Inc. (NASDAQ:VINO) fell 13.3% to $0.49 in pre-market after jumping 20% on Wednesday.
    • Esports Entertainment Group, Inc. (NASDAQ:GMBL) fell 13.3% to $0.0104 in pre-market trading. Esports Entertainment shares fell 41% on Wednesday after the company announced a 1-for-400 reverse stock split.
    • Passage Bio, Inc. (NASDAQ:PASG) shares fell 9.8% to $0.7344 in pre-market trading after gaining 7% on Wednesday. Passage Bio announced initial safety and biomarker data from three Cohort 1 patients in the ongoing global Phase 1/2 upliFT-D clinical trial evaluating PBFT02, an adeno-associated virus (AAV)-delivery gene therapy for frontotemporal dementia (FTD) with granulin (GRN) mutations.
    • InMed Pharmaceuticals Inc. (NASDAQ:INM) shares fell 9.4% to $0.33 in pre-market trading.
    • iCoreConnect Inc. (NASDAQ:ICCT) shares fell 8.7% to $1.56 in pre-market trading.

     

    Now Read This: Top 4 Health Care Stocks That May Crash This Month

    Get the next $ACON alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $ACON
    $ATAK
    $BB
    $DUNE

    CompanyDatePrice TargetRatingAnalyst
    Passage Bio Inc.
    $PASG
    4/21/2026Buy → Hold
    TD Cowen
    Passage Bio Inc.
    $PASG
    4/21/2026$7.00Buy → Neutral
    Chardan Capital Markets
    Passage Bio Inc.
    $PASG
    4/21/2026$8.00Outperform → Neutral
    Wedbush
    Micron Technology Inc.
    $MU
    4/3/2026Buy → Hold
    Erste Group
    Micron Technology Inc.
    $MU
    4/2/2026Buy → Hold
    Erste Group
    Passage Bio Inc.
    $PASG
    3/31/2026$30.00Outperform
    Oppenheimer
    Micron Technology Inc.
    $MU
    3/19/2026Buy → Hold
    Summit Insights
    Micron Technology Inc.
    $MU
    3/19/2026$450.00 → $500.00Buy
    Needham
    More analyst ratings

    $ACON
    $ATAK
    $BB
    $DUNE
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Passage BIO downgraded by TD Cowen

    TD Cowen downgraded Passage BIO from Buy to Hold

    4/21/26 9:31:55 AM ET
    $PASG
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    Passage BIO downgraded by Chardan Capital Markets with a new price target

    Chardan Capital Markets downgraded Passage BIO from Buy to Neutral and set a new price target of $7.00

    4/21/26 7:30:00 AM ET
    $PASG
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    Passage BIO downgraded by Wedbush with a new price target

    Wedbush downgraded Passage BIO from Outperform to Neutral and set a new price target of $8.00

    4/21/26 7:29:39 AM ET
    $PASG
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    $ACON
    $ATAK
    $BB
    $DUNE
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 4 filed by Allen Scott R.

    4 - MICRON TECHNOLOGY INC (0000723125) (Issuer)

    4/17/26 7:02:49 PM ET
    $MU
    Semiconductors
    Technology

    SEC Form 4 filed by Rudelius Robert James

    4 - PetVivo Holdings, Inc. (0001512922) (Issuer)

    4/17/26 4:22:18 PM ET
    $PETV
    Medical/Dental Instruments
    Health Care

    SEC Form 4 filed by Cordano Michael D

    4 - MICRON TECHNOLOGY INC (0000723125) (Issuer)

    4/16/26 7:08:26 PM ET
    $MU
    Semiconductors
    Technology

    $ACON
    $ATAK
    $BB
    $DUNE
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    A $550 Billion Opportunity: Drones-as-a-Service Emerges as Defense's Next Growth Engine

    Governments are accelerating investments in scalable autonomous drone operations without the burden of fleet ownershipMarket News Updates News Commentary CounterNEW YORK, April 23, 2026 /CNW/ -- Drones-as-a-Service (DaaS) is quickly becoming a major shift in how military and defense organizations actually use drone technology in the field. Instead of spending heavily to purchase and maintain their own fleets, agencies can now tap into drone capabilities like aerial surveillance, mapping, logistics delivery, and ISR (intelligence, surveillance, and reconnaissance) whenever they're needed. It works a lot like a cloud subscription model—giving operators access to the latest hardware, AI-powered

    4/23/26 9:00:00 AM ET
    $PRZO
    $RCAT
    $UAVS
    Military/Government/Technical
    Industrials
    Computer Software: Prepackaged Software
    Technology

    ParaZero Expands European Presence with New Reseller Agreement and Initial Demo Kit Procurement in Romania

    Kfar Saba, Israel, April 23, 2026 (GLOBE NEWSWIRE) -- ParaZero Technologies Ltd. (NASDAQ:PRZO) (the "company" or "ParaZero"), an aerospace defense company pioneering smart, autonomous solutions for the global manned and unmanned aerial systems (UAS) industry, today announced the signing of a new reseller agreement with New Akord Security, a Romania-based defense and homeland security integrator. The agreement expands ParaZero's commercial footprint in the region and reinforces its growing presence across Europe, particularly among NATO member states near the Russia-Ukraine conflict zone. New Akord Security will market ParaZero's DefendAir system across Romania and provide end users with

    4/23/26 7:55:00 AM ET
    $PRZO
    Military/Government/Technical
    Industrials

    Aclarion Announces $2.5 Million Stock Repurchase Plan

    BROOMFIELD, Colo., April 22, 2026 (GLOBE NEWSWIRE) -- Aclarion, Inc., ("Aclarion" or the "Company") (NASDAQ:ACON, ACONW)), a commercial-stage healthcare technology company leveraging biomarkers and proprietary augmented intelligence (AI) algorithms through its Nociscan platform to help physicians identify the location of chronic low back pain and support improved treatment success rates, today announced that its Board of Directors has authorized a share repurchase program of up to $2.5 million of the Company's outstanding common stock. Aclarion expects to execute the repurchase program over the next 12 months. The timing, volume, and nature of repurchases will be determined by the Company

    4/22/26 8:30:00 AM ET
    $ACON
    Medical Specialities
    Health Care

    $ACON
    $ATAK
    $BB
    $DUNE
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Large owner A.L. Sarroff Fund, Llc bought 1,250,000 shares (SEC Form 4)

    4 - PetVivo Holdings, Inc. (0001512922) (Issuer)

    3/13/26 5:10:25 PM ET
    $PETV
    Medical/Dental Instruments
    Health Care

    Large owner A.L. Sarroff Fund, Llc converted options into 974,809 shares and bought $77,999 worth of shares (154,840 units at $0.50) (SEC Form 4)

    4 - PetVivo Holdings, Inc. (0001512922) (Issuer)

    1/16/26 4:38:39 PM ET
    $PETV
    Medical/Dental Instruments
    Health Care

    Large owner A.L. Sarroff Fund, Llc bought $485,355 worth of shares (718,358 units at $0.68) and converted options into 4,033,209 shares (SEC Form 4)

    4 - PetVivo Holdings, Inc. (0001512922) (Issuer)

    1/16/26 4:38:14 PM ET
    $PETV
    Medical/Dental Instruments
    Health Care

    $ACON
    $ATAK
    $BB
    $DUNE
    SEC Filings

    View All

    Mobile Global Esports Inc. filed SEC Form 8-K: Leadership Update, Financial Statements and Exhibits

    8-K - Mobile Global Esports, Inc. (0001886362) (Filer)

    4/23/26 9:23:24 PM ET
    $MGAM
    Services-Misc. Amusement & Recreation
    Consumer Discretionary

    SEC Form 6-K filed by ParaZero Technologies Ltd.

    6-K - ParaZero Technologies Ltd. (0001916241) (Filer)

    4/23/26 8:20:25 AM ET
    $PRZO
    Military/Government/Technical
    Industrials

    SEC Form SD filed by BlackBerry Limited

    SD - BLACKBERRY Ltd (0001070235) (Filer)

    4/22/26 12:45:38 PM ET
    $BB
    Computer Software: Prepackaged Software
    Technology

    $ACON
    $ATAK
    $BB
    $DUNE
    Leadership Updates

    Live Leadership Updates

    View All

    Dr. Teresa Montagut Appointed as Clinical Development and Medical Affairs Head at Mesoblast

    NEW YORK, March 11, 2026 (GLOBE NEWSWIRE) -- Mesoblast Limited (NASDAQ:MESO, ASX:MSB)), global leader in allogeneic cellular medicines for inflammatory diseases, today announced the appointment of Teresa Montagut MD, PhD in the newly established position of Head of Clinical Development and Medical Affairs reporting to the Chief Medical Officer Dr. Eric Rose. In this role, Teresa will lead Mesoblast's medical affairs organization, fostering clinical collaborations and spearheading investigator-initiated trials, enhancing clinical and medical communications, and engaging with healthcare professionals. She will play a critical role in unlocking the value of Mesoblast's cell therapy programs i

    3/11/26 7:21:39 PM ET
    $MESO
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    Vertiv Holdings, Lumentum Holdings, Coherent, and EchoStar Set to Join S&P 500; Others to Join S&P 100, S&P MidCap 400, and S&P SmallCap 600

    NEW YORK, March 6, 2026 /PRNewswire/ -- S&P Dow Jones Indices ("S&P DJI") will make the following changes to the S&P 100, S&P 500, S&P MidCap 400, and S&P SmallCap 600 indices: NAPCO Security Technologies Inc. (NASD: NSSC) will replace Alexander & Baldwin Inc. (NYSE:ALEX) in the S&P SmallCap 600 effective prior to the opening of trading on Friday, March 13. An investor group comprised of MW Group and funds affiliated with DivcoWest and Blackstone Real Estate is acquiring Alexander & Baldwin in a deal that is expected to close soon, pending final closing conditions.The following changes to the S&P 100, S&P 500, S&P MidCap 400, and S&P SmallCap 600 will take effect before the market opens on M

    3/6/26 6:39:00 PM ET
    $AGX
    $AHRT
    $AIG
    Engineering & Construction
    Consumer Discretionary
    Real Estate
    Finance

    ParaZero Strengthens Global Sales Leadership with Appointment of Bat-Sheva Noy as VP

    Kfar Saba, Israel, March 04, 2026 (GLOBE NEWSWIRE) -- ParaZero Technologies Ltd. (NASDAQ:PRZO) (the "company" or "ParaZero"), an aerospace defense company pioneering smart, autonomous solutions for the global manned and unmanned aerial systems (UAS) industry, recently announced the appointment of Bat-Sheva Noy as its new Vice President of Global Sales. Ms. Noy brings more than 20 years of extensive commercial and leadership experience, with particular expertise in strategic planning, market access, and leading cross-functional teams. Most recently, from 2020 to 2025, she served as the Business Unit Lead for Rare Diseases at Pfizer Israel ((a subsidiary of Pfizer Inc., NYSE:PFE). In that

    3/4/26 8:32:00 AM ET
    $PFE
    $PRZO
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Military/Government/Technical
    Industrials

    $ACON
    $ATAK
    $BB
    $DUNE
    Financials

    Live finance-specific insights

    View All

    Mesoblast Acquires Chimeric Antigen Receptor (CAR) Platform Technology for Precision-Enhanced Cell Products

    NEW YORK, April 14, 2026 (GLOBE NEWSWIRE) -- Mesoblast Limited (NASDAQ:MESO, ASX:MSB)), global leader in allogeneic cellular medicines for inflammatory diseases, today announced that it has acquired an exclusive worldwide license to a patented chimeric antigen receptor (CAR) technology platform for precision-enhanced augmentation of therapeutic mesenchymal lineage stromal cell (MSC) products. Mesoblast plans to incorporate the engineered CARs to further boost effectiveness of Mesoblast's products, with the goal of enhancing the target specificity and augmenting inherent properties of immunomodulation and tissue regeneration. Mesoblast's MSC technology platforms, including the first and on

    4/14/26 8:10:56 PM ET
    $MESO
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    Aclarion, Inc. Adopts Limited Duration Stockholder Rights Plan

    BROOMFIELD, Colo., March 19, 2026 (GLOBE NEWSWIRE) -- Aclarion, Inc. (NASDAQ:ACON, ACONW)) ("Aclarion" or the "Company") today announced that its Board of Directors (the "Board") has unanimously adopted a limited duration stockholder rights plan (the "Rights Plan"). The Rights Plan is effective immediately and expires in one year. The Rights Plan is intended to enable all stockholders to realize the long-term value of their investment in Aclarion. The Rights Plan is also intended to reduce the likelihood that any person or group gains control of the Company without paying all stockholders an appropriate control premium. The Rights Plan will help to ensure the Board has sufficient time to

    3/19/26 9:25:40 AM ET
    $ACON
    Medical Specialities
    Health Care

    Micron Technology, Inc. Reports Results for the Second Quarter of Fiscal 2026

    BOISE, Idaho, March 18, 2026 (GLOBE NEWSWIRE) -- Micron Technology, Inc. (NASDAQ:MU) today announced results for its second quarter of fiscal 2026, which ended February 26, 2026. Fiscal Q2 2026 highlights Revenue of $23.86 billion versus $13.64 billion for the prior quarter and $8.05 billion for the same period last yearGAAP net income of $13.79 billion, or $12.07 per diluted shareNon-GAAP net income of $14.02 billion, or $12.20 per diluted shareOperating cash flow of $11.90 billion versus $8.41 billion for the prior quarter and $3.94 billion for the same period last year "Micron set new records across revenue, gross margin, EPS, and free cash flow in fiscal Q2, driven by a strong dem

    3/18/26 4:01:00 PM ET
    $MU
    Semiconductors
    Technology

    $ACON
    $ATAK
    $BB
    $DUNE
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by Mesoblast Limited

    SC 13G/A - MESOBLAST LTD (0001345099) (Subject)

    12/16/24 12:08:07 PM ET
    $MESO
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    Amendment: SEC Form SC 13G/A filed by iCoreConnect Inc.

    SC 13G/A - iCoreConnect Inc. (0001906133) (Subject)

    12/12/24 9:44:00 PM ET
    $ICCT
    Computer Software: Prepackaged Software
    Technology

    Amendment: SEC Form SC 13G/A filed by iCoreConnect Inc.

    SC 13G/A - iCoreConnect Inc. (0001906133) (Subject)

    12/5/24 4:08:58 PM ET
    $ICCT
    Computer Software: Prepackaged Software
    Technology